Abstract
The toxic effects of C9orf72-derived arginine-rich dipeptide repeats (R-DPRs) on cellular stress granules in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia remain unclear at the molecular level. Stress granules are formed through the switch of Ras GTPase-activating protein-binding protein 1 (G3BP1) by RNA from a closed inactive state to an open activated state, driving the formation of the organelle by liquid-liquid phase separation (LLPS). We show that R-DPRs bind G3BP1 a thousand times stronger than RNA and initiate LLPS much more effectively. Their pathogenic effect is underscored by the slow transition of R-DPR-G3BP1 droplets to aggregated, ThS-positive states that can recruit ALS-linked proteins hnRNPA1, hnRNPA2, and TDP-43. Deletion constructs and molecular simulations show that R-DPR binding and LLPS are mediated via the negatively charged intrinsically disordered region 1 (IDR1) of the protein, allosterically regulated by its positively charged IDR3. Bioinformatic analyses point to the strong mechanistic parallels of these effects with the interaction of R-DPRs with nucleolar nucleophosmin 1 (NPM1) and underscore that R-DPRs interact with many other similar nucleolar and stress-granule proteins, extending the underlying mechanism of R-DPR toxicity in cells. Our results also highlight characteristic differences between the two R-DPRs, poly-GR and poly-PR, and suggest that the primary pathological target of poly-GR is not NPM1 in nucleoli, but G3BP1 in stress granules in affected cells.
Original language | English |
---|---|
Article number | e2402847121 |
Number of pages | 12 |
Journal | Proceedings of the National Academy of Sciences |
Volume | 121 |
Issue number | 50 |
DOIs | |
Publication status | Published - 10 Dec 2024 |
Bibliographical note
Funding Information:We personally thank Prof. Paul Taylor (St. Jude Children's Research Hospital, Memphis, TN) for providing the construct of full-length G3BP1, and Antonio Maisto (Vrije Universiteit Brussel (VUB)) for familiarization with microfluidic experiments. We would like also to acknowledge funding from the following sources: EC H2020-WIDESPREAD-2020-5 Twinning grant (PhasAge, no. 952334, to P.T.), and EC H2020-MSCA-RISE Action grant (IDPfun, no. 778247, to P.T.); grants K124670 and K131702 (to P.T.) and FK128133 and FK142285 (to R.P.) from the National Research, Development and Innovation Office (NKFIH), Hungary; Bolyai fellowship BO/00174/22 (to R.P.) from the Hungarian Academy of Sciences; E\u00F6tv\u00F6s Research Fellowship no. 184018 (to R.P.) from the Tempus Public Foundation; VUB Strategic Research Programs (SRP51 and SRP97) at Vrije Universiteit Brussel (VUB, Brussels, to M.V.N., D.M., W.D.M., and P.T.); European Space Agency (ESA) grant A0-2004-070 (to D.M. and Q.G.); Fonds Wetenschappelijk Onderzoek (FWO) PhD fellowships in strategic basic research (FWOSB77, to J.A. and 11D2522N, to J.V.L.); postdoctoral innovation mandate (HBC.2022.0194) by the Flanders Innovation & Entrepreneurship Agency (VLAIO, to T.L.).
Publisher Copyright:
Copyright © 2024 the Author(s). Published by PNAS.